Lipocortin I gene expression is higher in blood monocytes than in BAL fluid macrophages in patients with pulmonary sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 15, Issue 1, 1998, Pages 38-43

  Mikuniya, Takeshi ^a   Nagai, Sonoko ^a   Morita, Koji ^a   Mio, Tadashi ^a   Satake, Norio ^a   Izumi, Takateru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cell activation and differentiation; Idiopathic pulmonary fibrosis; Lipocortin I; Macrophages monocytes; RT PCR; Sarcoidosis

Indexed keywords

LIPOCORTIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG LAVAGE; LUNG SARCOIDOSIS; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANNEXIN A1; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; MONOCYTES; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY;

EID: 0031947459     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nagai S, Izumi T: Pulmonary sarcoidosis: Population Differences and Pathophysiology. South Med J 1995; 88: 1001-1010.
2. Hunninghake GW, Gadek JE, Young RC, Kawakami O, Ferrans VJ, Crystal RG: Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med 1980; 302: 594-598.
3. Romer FK, Christiansen SE, Kragballe K, Herlin T, Madsen M: Studies of peripheral blood monocyte in pulmonary sarcoidosis. Clin Exp Immunol 1984; 58-2: 357-363.
4. Rossman MD, Chien P, Cassizzi A, Elias JA, Schreiber AD: Increased monocyte Fc (IgG) receptor expression in sarcoidosis. Ann NY Acad Sci 1986; 465: 260-267.
5. Terao I, Hashimoto S, Horie T: Effects of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis. Int Arch Allergy Immunol 1993; 102: 242-243.
6. Hance AJ, Douches S, Winchester RJ, Ferrans VJ, Crystal RG: Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies; chances in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J Immunol 1985; 134: 284-292.
7. Hocking WG, Golde DW: The pulmonary alveolar macrophage. N Engl J Med 1979; 300: 580-587.
8. Okabe T, Yamagata K, Fujisawa M et al: Increased angiotensin-converting enzyme in peripheral blood monocytes from patients with sarcoidosis. J Clin Invest 1985; 75: 911-914.
9. Ohta M, Okabe T, Ozawa K, Urabe A, Takaku F: In vitro formation of macrophage-epithelioid cells and multinucleated giant cells by 1 alpha, 25-dihydroxy vitamin D3 from human circulating monocytes. Ann NY Acad Sci 1986; 465: 211-220.
10. Hunninghake GW, Garrett KC, Richerson JC et al: Pathogenesis of the granulomatous lung diseases. Am Rev Respir Dis 1984; 130: 476-496.
11. Crino G, Peers SH, Flower RJ, Browning JL, Pepinsky RB: Human recombinant lipocortin I has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci USA 1989; 86: 3428-3442.
12. Davidson FF, Dennis EA, Powell M, Glenney Jr JR: Inhibition of phospholipase A2 by "lipocortin" and calpactin. J Biol Chem 1987; 262: 1698-1705.
13. Hirata F: Role of lipomodulin: a phospholipase inhibitory protein in immunoregulation. In: Otterness I, Capetola R, Wong S, Eds. Advances in Inflammation Research. New York: Raven Press, 1984; 7: pp. 71-78.
14. Perretti M, Flower RJ: Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993; 150: 992-999.
15. 2 production by human recombinant lipocortin I. Br J Pharmacol 1988; suppl. 93-95: 139P.
16. Maridonneau-Parini I, Errasfa M, Russo-Marie E: Inhibition of O2-generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J Clin Invest 1989; 83: 1936-1940.
17. Nicolas JG, Paul MG: Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interaction with Fcγ receptors. Biochem Biophys Res Commun 1993; 192: 351-358.
18. Hirata F, Iwata M: The role of lipomodulin, a phospholipase inhibitory protein in immunoregulation by thymocytes. J Immunol 1983; 130: 1930-1936.
19. Solito E, Raugei G, Melli M, Parente L: Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated but not undifferentiated U-937 cells. FEBS Letters 1991; 291: 238-244.
20. Hattori T, Thomas H, Hirata F: Differentiation of a histocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory protein. Biochem Biophys Res Commun 1983; 111-2: 551-559.
21. Ambrose MP, Bahns C-LC, Hunninghake GW: Lipocortin 1 production by human alveolar macrophages. Am J Respir Cell Biol 1992; 6: 17-21.
22. Nagai S, Hting A, Takeuchi M, Kusume K, Izumi T: IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 1991; 99: 674-680.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
24. Carre PC, Mortenson RL, King TE, Noble PW, Sable CL, Riches DW: Increased expression of the interleukin 8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991; 88: 1802-1810.
25. Schmitt JF, Guthridge M, Economou C, Bertolini J, Hearn MT: A new quantitative polymerase chain reaction high liquid chromatographic method for detection of fibroblast growth factor-β (FGF-β) gene amplification. J Biochem Biophys Methods 1992; 24: 119-133.
26. Dawson-Saunders B, Trapp R.G: Basic and Clinical Biostatistics, 2nd ed. Prentice-Hall International, London, 1994; pp. 189-209.
27. Costabel U, Bross KJ, Reuter C, Ruhle K-H, Matthys H: Alterations in immunoregulatory T cell subsets in cigarette smokers. A phenotypic analysis of bronchoalveolar and blood lymphocytes. Chest 1986; 90: 39-44.
28. Schaberg T, Lauer C, Lode H, Fischer J, Haller H: Increased number of alveolar macrophages expressing adhesion molecules of the leukocyte adhesion molecule family in smoking subjects. Association with cell-binding ability and superoxide anion production. Am Rev Respir Dis 1992; 146: 1287-1293.
29. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR: Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 1995; 76: 195-202.
30. Striz I, Zheng L, Wang YM, Pokorna U, Bauer PC, Costabel U: Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14. Am J Respir Crit Care Med 1995; 151: 544-547.
31. Haslam PL, Parker DJ, Townsend PJ: Increases in HLA-DQ, DP, DR, and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis compared with fibrosing alveolitis. Chest 1990; 9: 651-661.
32. Goulding NJ, Godolphin JL, Sharland PR et al: Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990; 335: 1416-1418.
33. De-Caterina R, Sicari R, Giannessi D et al: Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol 1993; 75: 2368-2375.
34. Turton CWG, Grundy E, Firth G, Mitchell D, Rigden BG, Turner-Warwick M: Corticosteroid treatment in sarcoidosis: do serial lavage lymphocyte counts, serum ACE measurements and gallium-67 scans help management? Thorax 1979; 34: 57-62.
35. Prior C, Haslam PL: Increased levels of serum interferon-gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Respir Dis 1991; 143: 53-60.